AI assistant
USCOM LIMITED — Investor Presentation 2016
Oct 5, 2016
65979_rns_2016-10-05_d21264b7-c97b-4588-8ed5-4260e21a68e2.pdf
Investor Presentation
Open in viewerOpens in your device viewer
Uscom (UCM) – Global Medical Devices
Moving Forward FY 2016-2017
==> picture [842 x 118] intentionally omitted <==
Rob Phillips PhD(med), MPhil(med), FASE, DMU(cardiol) Associate Professor, Critical Care Research Group, School of Medicine, The University of Queensland Uscom Executive Chairman/CEO
The Measure of Life
Disclaimer
This presentation is intended to provide a general outline only and is not intended to be a definitive statement on the subject matter. The information in this presentation, whether written or verbal, has been prepared without taking into account the commercial, financial or other needs of any individual or organisation.
While Uscom (the "Company”) has taken due care in compiling the information, neither the Company nor its officers or advisors or any other person warrants the accuracy, reliability, completeness or timeliness of the information or guarantees the commercial or investment performance of the Company. Certain information may relate to protected intellectual property rights owned by Uscom. By viewing this presentation the viewer accepts the terms of the Company NDA.
The information does not constitute advice of any kind and should not be relied on as such. Investors must make their own independent assessment of the Company and undertake such additional enquiries as they deem necessary or appropriate for their own investment purposes. Any and all use of the information is at your own risk.
Uscom
“Digital medical device innovations to improve the physician experience and patient outcomes.”
==> picture [171 x 68] intentionally omitted <==
==> picture [125 x 127] intentionally omitted <==
==> picture [171 x 67] intentionally omitted <==
Digital Doppler Suprasystolic Ultrasound Oscillometry
Digital Transit time Ultrasound
New generation digital cardiovascular pulmonary devices.
Uscom – Medical devices the experts use
Uscom - Products
Sector leading technologies
Fluid, Sepsis
& Heart Failure
-
US $1.3bn market[*]
-
CAGR of 7.6%[*]
-
CE, FDA, TGA, CFDA
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [4 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [4 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [4 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [4 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [4 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [4 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [4 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [4 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [5 x 4] intentionally omitted <==
==> picture [4 x 4] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
Hypertension & Vascular Health
COPD
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [4 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
==> picture [5 x 5] intentionally omitted <==
& Asthma
-
US $1.7bn market[*]
-
US $400m market[*]
-
CAGR of 11.5%[*]
-
CAGR of 6.5%[*]
-
CE, FDA, TGA
-
CE, TGA, FDA
USCOM 1A
BP+
Cardiac Output Monitoring Blood Pressure Monitoring
SpiroSonic Pulmonary Monitoring
==> picture [141 x 113] intentionally omitted <==
==> picture [125 x 127] intentionally omitted <==
- Source: MedTech Insight; Transparency Market Research
Uscom – Devices the experts use
UCM – 2016
Not only growth: Record revenue, sales, cash, share price, cap value (+44 to114%) But investment: Transformational $65m 5yr China agreement Acquired and consolidated Thor laboratories into Uscom One off investments:
≈ acquisition and integration ( $1m) ≈ two new product lines for revenue in 2017 ( $0.5m) global corporate model established Approaching profitability with two new device series for sale in 2017
Uscom – Medical devices the experts use
UCM – 2016 Results
Total Revenue
Receipts from Customers
==> picture [748 x 298] intentionally omitted <==
----- Start of picture text -----
$3,500,000
2,563,145
2,500,000
$2,936,504
$3,000,000
2,000,000
$2,500,000
$2,039,426
$2,000,000
1,500,000
1,321,080
$
$1,500,000 $1,377,716
1,000,000
829,424
$1,010,942
$1,000,000 $864,099
621,253
500,000
$500,000
$0 -
2012 2013 2014 2015 2016 2013 2014 2015 2016
----- End of picture text -----
Total revenue +44% to $2.94m +43% CAGR for 3 years
Receipts from Customers +94% to $2.56m +60% CAGR for 3 years
Right company, right time…..
- Estimate
UCM – 2016 Results
Quarterly Total Revenue
Quarterly Cash Receipts
==> picture [732 x 280] intentionally omitted <==
----- Start of picture text -----
900000
700,000
800000
600,000
700000
600000 500,000
500000
400,000
$ $
400000
300,000
300000
200,000
200000
100000 100,000
0 0
Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
13 13 14 14 14 14 15 15 15 15 16 16 16 16 13 13 14 14 14 14 15 15 15 15 16 16 16 16
----- End of picture text -----
2016 – Total Revenue and Cash Receipts CAGR 44% and 94% CAGR 3 years
Right company, right time…..
- Estimate
UCM – 2016 Results
==> picture [513 x 344] intentionally omitted <==
----- Start of picture text -----
Cash, Equity and Assets
6,000,000
5,711,746
4,937,991
5,000,000
4,000,000
2,936,355
$ 3,000,000 2,839,773 2015
2016
2,288,661
2,000,000
1,290,796
992,796
1,000,000
526,317
0
Cash Cash Spend Equity Assets
----- End of picture text -----
2016 – A year of investment
Right company, right time…..
- Estimate
UCM – 2016 Results
Perfomance FY2016 Indices, Top 10 Superannuation funds and UCM
==> picture [766 x 361] intentionally omitted <==
----- Start of picture text -----
70
61
60
50
Indices Top 10 Super Funds
40
30
20 16.3
10.6
10 7.6 7 5.9 5.7 5.5 5.5 5.4 5.1 5 4.5
0
-2.3
-10 -5.2
-7.5
-10.1
-20
-30 -25.8
-40
The Top 10 Australian Superannuation Funds,
"Australian”, Financial Services, p22, 20th July 2016
% Growth
----- End of picture text -----
A simple comparison…..
UCM – 2016 Results
" Investors can review Uscom’s progress in 2016 with satisfaction and look forward to the rewards of 2017 and beyond. Uscom has invested in the future, and an investment in Uscom is an investment in the future.”
Uscom – Medical devices the experts use
Products USCOM 1A
Heart failure, hypertension, sepsis, fluid Non invasive, accurate, compact, platform technology
Accurate cardiac output
Cardiac stroke volume Systemic vascular resistance Left + right heart measurement
==> picture [308 x 250] intentionally omitted <==
Works with all other hospital equipment Intuitive touch screen Real time data Platform technology with multiple uses
Non invasive, real time, beat-to-beat haemodynamics
Uscom – Devices the experts use
New Products
Hypertension, heart failure and vascular disease Central Blood Pressure and Pulse Wave Analysis The new standard for hypertension
-
FDA, CE Mark, TGA approvals
-
• Supra-systolic Oscollometry
-
Reliable and
-
accurate
-
Central and
-
Brachial BP
-
Replaces sub-systolic methods (cuff)
-
Home or clinic
-
• PPW Analysis
-
• Results in
-
30 seconds
-
• No training required
-
• Platform technology with multiple uses
Stand alone, non invasive, accurate, compact system with BP+Reporter For launch FY 2017 Uscom – Devices the experts use
New Products Series
Digital Ultrasonic Spirometry New Standards of Pulmonary Testing Devices Applications Software
==> picture [177 x 30] intentionally omitted <==
==> picture [177 x 30] intentionally omitted <==
==> picture [177 x 31] intentionally omitted <==
==> picture [111 x 60] intentionally omitted <==
==> picture [111 x 60] intentionally omitted <==
==> picture [165 x 40] intentionally omitted <==
==> picture [165 x 40] intentionally omitted <==
==> picture [165 x 39] intentionally omitted <==
==> picture [177 x 30] intentionally omitted <==
For launch FY 2017 Uscom – Devices the experts use
New Products tSpiro
Uscom sells technologies others are researching High fidelity digital ultrasonic spirometers
==> picture [112 x 61] intentionally omitted <==
==> picture [112 x 60] intentionally omitted <==
-
Connecting patients to clinicians
-
US revenue (more than 400 sold)
-
Software analytics
-
Telemetric signals to cloud via iPhone
-
Cloud based processing/diagnosis
-
Personalised clinical advice - medication and dosage
-
Trend monitoring of multiple measures
-
Home care market
-
Capital and subscription revenue
-
Global partners – China, US, Euro
-
Multiple software providers – few hardware providers
-
CE, FDA and TGA. CFDA (in submission)
Aus - Resapp (RAP) – Cap $300m, Adherium (ADR) – Cap $60m, Uscom (UCM) – Cap $28m US - Cohero, Gecko, Asthma Sense, Propeller Health
- Uscom Sydney
2. Uscom London
Uscom Global
Delivering multiple products into multiple jurisdictions
2 •[•] • •[• •] • •• 3
[• ] • • • • •[•] •
[•] • •
[•] • 4 •• • •• • • •
•
Key Markets Asia
• • •[•] •
Europe Nth America
Focus FY 2017
-
Uscom Budapest
-
Uscom LA
-
Uscom Shanghai
• 5
• 1
Asia – Establish CIIC US – BP+ and SpiroSonic release Global tSpiro partnerships
China is Important
State funded growth
==> picture [462 x 334] intentionally omitted <==
----- Start of picture text -----
China Health Expenditure as % of GDP
7.9
6.5
5.1 5.0 5.1 [5.4]
4.6 [4.84.8 4.7 4.7]
4.6 4.4 [4.6]
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2018E 2020E
----- End of picture text -----
CIIC to distribute $65m of Uscom devices and support regulatory over 5 yrs
China Health Spend (USD) GDP=12,000,000,000,000 Health=5.4%=648,000,000,000 Objective=12%=1,400,000,000,000 Growth(+6.6%)=$792,000,000,000
Uscom China Targets (USD) Population = 1.35b 3 provinces < 10% pop = $10m 31 Provinces = 100% 10 x current UCM revenue = $10m 2 new products = $20m Total revenue China = $30m USD
Uscom positioning to grow with China - $30m pa revenue target
CIIC China
==> picture [479 x 227] intentionally omitted <==
==> picture [105 x 64] intentionally omitted <==
5 year importation and wholesale agreement with Shanghai CIIC Science and Technology Development Corp targeted to generate A$65m sales.
==> picture [180 x 43] intentionally omitted <==
==> picture [144 x 28] intentionally omitted <==
==> picture [92 x 45] intentionally omitted <==
==> picture [137 x 41] intentionally omitted <==
CIIC S&T – State owned company CIIC revenue – $10b USD, Med Device Division $250m USD
Uscom – Medical devices the experts use
CIIC China
==> picture [105 x 64] intentionally omitted <==
“We plan to make Uscom one of the leading medical device brands in China over the next five years.”
Daniel Sun, Head of BD and Marketing, Shanghai CIIC Science and Technology, Medical Device division
Uscom – Medical devices the experts use
CIIC China
==> picture [105 x 65] intentionally omitted <==
==> picture [592 x 395] intentionally omitted <==
http://www.bloomberg.com/news/articles/2016-07-05/china-inc-goes-on-a-buying-spree-for-global-health-care-assets
Uscom – Medical devices the experts use
==> picture [152 x 116] intentionally omitted <==
UCM - Media
==> picture [334 x 95] intentionally omitted <==
==> picture [247 x 63] intentionally omitted <==
==> picture [334 x 95] intentionally omitted <==
Alan Kohler
Peter Switzer Fox TV
==> picture [347 x 190] intentionally omitted <==
==> picture [308 x 95] intentionally omitted <==
CNBC Asia Tom Piotrowski Uscom – Medical devices the experts use
UCM - Media
==> picture [423 x 216] intentionally omitted <==
==> picture [423 x 217] intentionally omitted <==
==> picture [340 x 47] intentionally omitted <==
With improved operational performance has come increased media and international investor interest
The Australian, 5-3-16 Sarah-Jane Tasker
Uscom
“Time and again we find similar traits among long-term winners:
1. Led by founders with their fortunes and legacies on the line 2. Debt free and scalable operations 3. Willing to disrupt themselves ”
4. Have zealous, loyal customers.
Joe Magyer Australian Financial Review 22 June 2016
Uscom – Medical devices the experts use
Uscom – 2017 What we are going to do: Prepare BP+, SpiroSonic for market Regulatory approvals Manufacturing Distribution – strategic and effective partners of scale New revenue streams – BP+, SpiroSonic CIIC China sales Early US and Euro sales Continue growing USCOM 1A sales
Uscom – Medical devices the experts use
Uscom – 2017
Bring three world leading product ranges toward profit
==> picture [772 x 338] intentionally omitted <==
----- Start of picture text -----
Global Profit
Concept Product Pilot Validation Regulatory Revenue
Distribution FY17
USCOM 1A ✓ ✓ ✓ ✓ ✓ ✓ ✓ ±✓
Uscom BP+ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ±✓
SpiroSonic ✓ ✓ ✓ ✓ ✓ ✓ ✓ ±✓
Investment to Profit
----- End of picture text -----
==> picture [528 x 23] intentionally omitted <==
----- Start of picture text -----
IP transformed into profit
26
----- End of picture text -----
Uscom – 2017
Regulatory – Uscom’s new generation of products are being prepared for approval and sale across multiple jurisdictions in 2017
==> picture [737 x 406] intentionally omitted <==
----- Start of picture text -----
|||||
|---|---|---|---|
|New revenue starting 2017|
|USCOM 1A|Uscom BP+|SpiroSonic|
|CE|(Europe)|2017|2017|
|✓|
|FDA|(USA)|2017|2017|
|✓|
|CFDA|(China)|2017|2017|
|✓|
|TGA|(Aus)|2017|2017|
|✓|
| Subject to regulatory approval|Uscom – Devices the experts use|
----- End of picture text -----
Revenue Model
==> picture [675 x 420] intentionally omitted <==
----- Start of picture text -----
SpiroSonic – FY 2017
Total Revenue
20,000,000
18,000,000
16,000,000 BP+ - FY 2017
14,000,000
12,000,000
SpiroSonic
$ 10,000,000
BP+
USCOM
8,000,000 USCOM
6,000,000
4,000,000
2,000,000
0
2015 2016 2017 2018 2019 2020
----- End of picture text -----*
$20m revenue by 2020 = 5 year CAGR of 58%
Uscom - 2017
"Uscom has acquired global assets to ensure reliable revenue growth for investors for the coming decade.
Our 2017 strategy is to deliver the devices we have acquired into global markets with partners of scale. We are confident that this will drive our revenue growth and underwrite long term profitability.”
Uscom – Medical devices the experts use
Uscom (UCM) – Global Medical Devices
Moving Forward FY 2016-2017
==> picture [842 x 118] intentionally omitted <==
Thank You
Rob Phillips
PhD(med), MPhil(med), FASE, DMU(cardiol) Associate Professor, Critical Care Research Group, School of Medicine, The University of Queensland Executive Chairman/CEO
Uscom – Medical devices the experts use
Business Summary
-
Premium noninvasive cardiovascular and pulmonary monitoring devices
-
Addressing the growing threat of superbugs, heart failure, hypertension and asthma
-
Validated, clinically accepted, cost and life saving devices with critical applications
-
Aggressive global growth strategy – acquisition and partnerships
-
IP protected and FDA, CE and CFDA regulatory approvals
-
Uscom BP+ and SpiroSonic for market FY 2017
-
$3m revenue 2016, $65m 5year deal starts 2017
==> picture [691 x 214] intentionally omitted <==
----- Start of picture text -----
Corporate Board & Management Financials
� ASX listed (UCM) � Rob Phillips, Chairman & CEO � Sales +94% 2016
� Headquartered in Sydney � Sheena Jack, Director � Revenue +44% 2016 ($3m)
� (HCF, Moneytime Health) �
Market cap of $28m Cash consumption - $1.2m
� 108m shares on issue � Christian Bernecker, Director � Gross Margins ~ 75%
(Stream)
� �
Rob Phillips, Founder and Cash ~ $2.8m
� David He, Director (J&J, McKinseys)
CEO, holds 18% of
company � Nick Schicht, General Manager
----- End of picture text -----
- Uscom Annual report
USCOM 1A Competitive Advantage
| Method | Manufacturer | Technology | Rel+Rep | Non- invasive |
Simple | Cost | Portable | SV beat to beat |
|---|---|---|---|---|---|---|---|---|
| USCOM 1A | Uscom | Doppler | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| BioZ | Samsung | BioImpedance | ✗ | ✓ | ✓ | ✗ | ✓ | ✗ |
| NiCOM | Cheetah | BioReactance | ✗ | ✓ | ✓ | ✗ | ✓ | ✗ |
| Nexfin | Bmeye | APP | ✗ | ✓ | ✓ | ✓ | ✓ | ✗ |
| CardioQ | Deltex | Doppler | ✓ | ✗ | ✓ | ✗ | ✓ | ✗ |
| LiDCO | LiDCO | LiCl dilutio +APP |
✓ | ✗ | ✗ | ✗ | ✗ | ✗ |
| LiDCOrapid | LiDCO | APP | ✗ | ✗ | ✓ | ✗ | ✗ | ✗ |
| PiCCO (mod Tx + PP) |
Pulsion | APP | ✓ | ✗ | ✗ | ✗ | ✗ | ✗ |
| FloTrac | Edwards | APP | ✗ | ✗ | ✗ | ✗ | ✗ | ✗ |
| PAC (Tx) | Many | Thermodilution | ✗ | ✗ | ✗ | ✗ | ✗ | ✗ |
Testimonials
“This machine is saving lives, there are no two ways about it.”
Professor Brendan Smith, Anesthetist, Intensivist and Emergency Physician, N.S.W. Dept of Health, Australia
“USCOM has changed the way I look at the cardiovascular status of my patients.
It’s part of the initial shock evaluation and monitored regularly thereafter…. USCOM has now been established as the standard of care.”
Dr Akash Deep, Director of Paediatric ICU, King's College Hospital, London
“The USCOM device is a simple method of accurately and noninvasively measuring central circulation, a goal of cardiology for many years. The device has the potential to change the way we approach management of sepsis, heart failure and hypertension.”
Professor Malcolm West, Cardiologist, Mayne Professor of Medicine at The University of Queensland School of Medicine, Brisbane, Australia and Uscom Medical Advisory Board Member.
“I have used USCOM for over 5 years now on our very sick children, and use it to guide management. We are now beginning multi-centre, global research which will define the way USCOM is used in Paediatric Departments across the world.”
Dr Joe Brierley, Consultant Intensivist, Great Ormond Street Hospital for Sick Children, London, UK.
“The USCOM device is really good; I use it in all my aneasthetics. I think there should be one on every ICU bed and on every anaesthetic patient.”
Dr Steve Woodford, Consultant Anaesthetist, circulatory researcher at Australian School of Advanced Medicine, and Uscom Investor,
“To parents and doctors this machine, USCOM, is priceless. This machine is thought to have saved baby Abbie’s life.
BBC Documentary “New machine helps save babies life”, 2010, Nottingham Children’s Hospital
Uscom – Medical devices the experts use
BP+ Competitive Advantage
==> picture [94 x 95] intentionally omitted <==
| Uscom BP+ | TensioMed | BPLab | IEM | Centron | AtCor |
|---|---|---|---|---|---|
| Australia | Hungary | Russia | Germany | UK | Australia |
| USD 3,500 | USD 6,000 | USD 7,000 | USD 7,000 | USD 6,300 | USD 20,000 |
| 1 min | 2 min | 2 min | 2 min | 1 min | 1 min |
| Stand-alone | ABP, needs computer | ABP, needs computer | ABP, needs computer | Stand-alone | Needs computer |
| CE, FDA, TGA | CE | CE | CE, FDA | CE | CE, FDA |
| Aortic + brachial waveform |
Central systolic BP | Rough waveform | Rough waveform | Rough waveform | Rough waveform |
| Physical model | Statistical regression | Transfer function | Transfer function | Transfer function | Transfer function |
Uscom – Medical devices the experts use
Why ?
Independent research from Cambridge University, Weill Cornell, University of California, Wales Heart Institute – BP+ = Four stars
==> picture [651 x 296] intentionally omitted <==
BP+ is on the international space station
McEniery CM, Cockcroft JR, Roman MJ, Franklin SS, Wilkinson AB. Central blood pressure: current evidence and clinical importance. Euro Heart J 2014;doi10.1093/ eurojeartj/eht565
SpiroSonic Competitive Advantage
==> picture [149 x 47] intentionally omitted <==
==> picture [94 x 77] intentionally omitted <==
==> picture [98 x 73] intentionally omitted <==
==> picture [80 x 86] intentionally omitted <==
==> picture [75 x 75] intentionally omitted <==
==> picture [88 x 87] intentionally omitted <==
==> picture [75 x 77] intentionally omitted <==
==> picture [99 x 76] intentionally omitted <==
| Uscom SpiroSonic |
Welch Allyn | Schiller | Sibelmed | Vitalograph | MIR | Carefusion | NDD |
|---|---|---|---|---|---|---|---|
| Australia | USA | Switzerland | Spain | USA | Italy | USA | Switzerland |
| SpiroSonic | SpiroPerfect | Spirovit SP-1 | Dataspir Touch | Pneumotrac | Spirodoc | Microloop | EasyOne PLus |
| USD 1,890 | USD 2,100 | USD 1,850 | USD 2,300 | USD 2,030 | USD 1,580 | USD 2,180 | USD 1,990 |
| Dual Path Ultrasound |
Diff Pressure | Diff Pressure | Turbine | Diff Pressure | Turbine | Turbine | Single Path Ultrasound |
| Accurate Auto calibration SpiroReporter Fully digital FreeFlo sensor Hygeinic SpO2 Bluetooth Rechargeable |
Multiple iterations |
Multiple iterations |
Multiple iterations |
Multiple iterations |
Multiple iterations Conssumable turbines |
Multiple iterations |
Accurate Consumable tube |
Uscom – Medical devices the experts use
CPT Codes and Re-Imbursement
| Product | Measure | Region | Code | Price(AUD) | Status |
|---|---|---|---|---|---|
| Uscom BP+ | Central BP | USA | 93050 | $25.60 | S* |
| USCOM 1A | Cardiac Output | USA | 76999 | $107.00 | S** |
| Cardiac Output | China | 310701023 | $44.00 | ✓ | |
| Cardiac Output | China | 220600010 | $13.50 + $2.50 measure |
✓ | |
| Cardiac Output | Australia | TBD | TBD | S** | |
| Uscom Thor | Spirometry | USA | 94010 | $51.43 | ✓ |
| Spirometry | USA | 94060 | $87.14 | ✓ | |
| Spirometry | USA | 94070 | $87.00 | ✓ | |
| Spirometry | USA | 94375 | $57.14 | ✓ | |
| Spirometry | Australia | 11506 | $20.55 | ✓ | |
| Spirometry | Australia | 11509 | $35.65 | ✓ | |
| Spirometry | Australia | 11512 | $61.75 | ✓ |
S[*] Subject to Software modification and FDA notification
S[**] Under submission
TBD –To be determined
Big Data and eHealth
Big data needs high quality sensors Uscom specialises in high quality non-invasive sensors
==> picture [90 x 47] intentionally omitted <==
- Software analytics
==> picture [90 x 47] intentionally omitted <==
-
Telemetric signals
-
Cloud based processing/diagnosis
-
Personalised clinical advice
==> picture [87 x 89] intentionally omitted <==
-
Medication and dosage
-
Serial monitoring
-
Multiple measures
-
Home care market
-
Subscription service model
==> picture [143 x 137] intentionally omitted <==
-
Global partner opportunities – China, US, Euro
-
Multiple software providers – few hardware providers
Stand alone, wireless, accurate, compact, digital devices
Uscom – Devices the experts use